The possibilities of abundant uterine bleeding therapy with combined oral contraceptive containing estradiol valerate and dienogest (a review)

Pestrikova T.Iu.

Kafedra akusherstva i ginekologii Dal'nevostochnogo gosudarstvennogo meditsinskogo universiteta, Khabarovsk

Iurasova E.A.

Kafedra akusherstva i ginekologii Dal'nevostochnogo gosudarstvennogo meditsinskogo universiteta, Khabarovsk

Iurasov I.V.

Kafedra akusherstva i ginekologii Dal'nevostochnogo gosudarstvennogo meditsinskogo universiteta, Khabarovsk

Sukhonosova E.L.

Dal'nevostochnyĭ gosudarstvennyĭ meditsinskiĭ universitet, Khabarovsk

The possibilities of abundant uterine bleeding therapy with combined oral contraceptive containing estradiol valerate and dienogest (a review)

Authors:

Pestrikova T.Iu., Iurasova E.A., Iurasov I.V., Sukhonosova E.L.

More about the authors

Journal: Russian Journal of Human Reproduction. 2017;23(6): 34‑38

DOI: 10.17116/repro201723634-38

Downloaded: 10

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Pestrikova TIu, Iurasova EA, Iurasov IV, Sukhonosova EL. The possibilities of abundant uterine bleeding therapy with combined oral contraceptive containing estradiol valerate and dienogest (a review). Russian Journal of Human Reproduction. 2017;23(6):34‑38. (In Russ.)
https://doi.org/10.17116/repro201723634-38

Close metadata

Recommended articles:

Acute gynecologic pathology in patients with COVID-19. Russian Bulletin of Obstetrician-Gynecologist. 2024;(4):56-62

Information about an abundant uterine bleeding and classification of the PALM-COEIN in non-pregnant women of reproductive age are presented. Classification of the PALM-COEIN includes nine major categories of uterine bleeding depending on the etiologic factor. The use of combined oral contraceptive containing estradiol valerate and dienogest is warranted in the COEIN category. The use of combined oral contraceptive with estradiol valerate and dienogest can reduce the amount of menstrual blood loss and the intensity of pain during menstruation. Role of this oral contraceptive is effective to the prevention of recurrent abnormal uterine bleeding and after polypectomy.

Keywords:

abnormal uterine bleeding

classification of the PALM-COEIN

combined oral contraceptive (estradiol valerate and dienogest)

Authors:

Pestrikova T.Iu.

Kafedra akusherstva i ginekologii Dal'nevostochnogo gosudarstvennogo meditsinskogo universiteta, Khabarovsk

Iurasova E.A.

Kafedra akusherstva i ginekologii Dal'nevostochnogo gosudarstvennogo meditsinskogo universiteta, Khabarovsk

Iurasov I.V.

Kafedra akusherstva i ginekologii Dal'nevostochnogo gosudarstvennogo meditsinskogo universiteta, Khabarovsk

Sukhonosova E.L.

Dal'nevostochnyĭ gosudarstvennyĭ meditsinskiĭ universitet, Khabarovsk

List of references:

Guide to reproductive medicine. Ed. Carra B. Blackwell R. and Aziza R. Per. with english. M.: Practice; 2015. (In Russ.)
Sharma S, Makaju R, Shrestha S, Shrestha A. Histopathological findings of endometrial samples and its correlation between the premenopausal and postmenopausal women in abnormal uterine bleeding. Kathmandu Univ Med J. 2014;12(48):275-278. https://doi.org/10.3126/kumj.v12i4.137347
Management of acute abnormal uterine bleeding in nonpregnant women. International Journal of Science and Research. 2016;5(3):273-275. https://doi.org/10.21275/v5i3.nov161858
Srivaths LS, Bercaw JL, Dietrich JE. Heavy menstrual bleeding. Management of Bleeding Patients. 2016:199-206. https://doi.org/10.1007/978-3-319-30726-8_22
Gynecology. National leadership: a short edition. Еds. Savelieva GM, Sukhikh GT, Manukhin IB. M: GEOTAR-Media; 2015. (In Russ.)
AlHilli MM, Hopkins MR, Famuyide AO. Endometrial cancer after endometrial ablation: systematic review of medical literature. Gynecologic Oncology. 2011;123(2):443. https://doi.org/10.1016/j.ygyno.2011.07.074
Cooper NA, Barton PM, Breijer M, Caffrey О, Opmeer ВС, Timmermans А, Mol ВWJ, Khan КS, Clark TJ Cost-effectiveness of diagnostic strategies for the management of abnormal uterine bleeding (heavy menstrual bleeding and post-meno-pausal bleeding): a decision analysis. Health Technol Assess. 2014;18(24). https://doi.org/10.3310/hta18240
Garg P, Yadav S. Comparison of transvaginal ultrasonography and hysteroscopy in the evaluation of peri and postmenopausal bleeding. Journal of Evolution of Medical and Dental Sciences. 2016;5(21):1133-1136. https://doi.org/10.14260/jemds/2016/263
Sakhel K, Abuhamad A. Sonography of adenomyosis. J Ultrasound Med. 2012;31:805-808. https://doi.org/10.7863/jum.2012.31.5.805
Weiss G, Maseelall Р, Schott LL, Brockwell SE, Schocken M., Johnston JM. Adenomyosis a variant not a disease? Evidence from hysterectomized menopausal women in the SWAN Study. Fertil Steril. 2009;91(1):201-206. https://doi.org/10.1016/j.fertnstert.2007.11.025
Munro MG, Critchley HO, Broder MS, Fraser IS, for the FIGO Working Group on Menstrual Disorders. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynecol Obstet. 2011;113(1):3-13. https://doi.org/10.1016/j.ijgo.2010.11.011
Pestrikova TYu, Danilenko IA, Boloniaeva NA, Gaponenko EK. Contraception: The effectiveness and safety of the use of an intrauterine levonorgestrel-releasing system. Gynecology. 2015;17(1):22-24. (In Russ.)
Abushahin N, Zhao R, Jia L, Zheng W. Endometrial precancers: from concept to practice. Diagnostic Histopathology. 2013;19(7):256-266. https://doi.org/10.1016/j.mpdhp.2013.06.004
Patel C, Ullal A, Roberts M, Brady J, Birch P, Bulmer JN, Wadehra V Endometrial carcinoma detected with SurePath liquid-based cervical cytology: comparison with conventional cytology. Cytopathology. 2009;20(6):380-387. https://doi.org/10.1111/j.1365-2303.2008.00621.x
Trimble CL, Kauderer J, Zaino R, Silverberg S, Lim PC, Burke JJ, Alberts D, Curtin J. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia. Cancer. 2006;106(4):812-819. https://doi.org/10.1002/cncr.21650
Hay DL, Walker CS, Poyner DR. Adrenomedullin and calcitonin generelated peptide receptors in endocrinerelated cancers: opportunities and challenges. Endocr Relat Cancer. 2010;18(1):1-14. https://doi.org/10.1677/erc-10-0244
Reproductive Medicine and Family Planning: A Practical Guide. McVay Е, Gillboud D, Hambag R. Ed. Prilepskoy VN. and Sukhikh GT. Trans. with english. М.: MEDPRESS-INFORM, 2016. (In Russ.)
Guide to contraception. Ed. Prilepskaya VN. 3rd ed., Pererab. and additional. М.: MEDPRESS-INFORM, 2014. (In Russ.)
AAGL Practice Report: Practice Guidelines for the Diagnosis and Management of Endometrial Polyps. Journal of Minimally Invasive Gynecology. 2012;19(1):3-10. https://doi.org/10.1016/j.jmig.2011.09.003
Lieng M, Istre O, Sandvik L, Qvigstad E. Prevalence, 1-year regression rate, and clinical significance of asymptomatic endometrial polyps: cross-sectional study. J Minim Invasive Gynecol. 2009;16(4):465-471. https://doi.org/10.1016/j.jmig.2009.04.005
Salim S, Won H, Nesbitt-Hawes E, Campbell N, Abbott J. Diagnosis and management of endometrial polyps: a critical review of literature. J Minim Invasive Gynaecol. 2011;18(5):569-581. https://doi.org/10.1016/j.jmig.2011.05.018
Paradisi R, Rossi S, Scifo MС, C, Dall’O’ F, Battaglia C, Venturoli S. Recurrence of endometrial polyps. Gynecol Obstet Invest. 2014;78(1):26-32. https://doi.org/10.1159/000362646
Yang J-H, Chen C-D, Chen S-U, Yang Y-S, Chen M-J. Factors influencing the recurrence potential of benign endometrial polyps after hysteroscopic polypectomy. PLОS ONE. 2015;10(12):e0144857. https://doi.org/10.1371/journal.pone.0144857
Mikhelson AF, Feoktistova TE, Lebedenko EYu, Mikhelson AA. Influence of the combination of estradiol valerate and dienogest on the frequency of relapses of hormone-sensitive polyps of the endometrium. Doktor RU. 2016;7(124):27-31. (In Russ.)
Seravalli V, Linari S, Peruzzi EE, Dei Dei М, Bruni V. Prevalence of hemostatic disorders in adolescents with abnormal uterine bleeding. J Pediatr Adolesc Gynecol. 2013;26(5):285-289. https://doi.org/10.1016/j.jpag.2013.06.003
Pestrikova TYu, Yurasova EA, Sukhonosova EL, Svidler NV. The possibility of using a contraceptive containing estradiol valerate and dienogest, in patients with polycystic ovary syndrome. The Russian bulletin of the obstetrician-gynecologist. 2013;13(5):75-77. (In Russ.)

Close metadata